Recent discussions surrounding pharmacy benefit manager (PBM) reforms have highlighted significant tensions within Congress. As lawmakers pursue a funding deal, PBM reform has notably been excluded from key spending packages, much to the dismay of pharmacists and health advocates who believe such reforms are critical for reducing prescription drug costs. Although some stopgap funding bills initially included provisions for PBM reform and maintaining telehealth options, last-minute changes have stripped these measures from the final agreements. This shift reflects the ongoing challenges in addressing healthcare reforms amid pressures to keep the government funded and operational. Stakeholders are calling for continued efforts to rein in PBMs, emphasizing the need for reform as part of broader healthcare legislative discussions.